Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 13 | 2024 | 704 | 2.480 |
Why?
|
| Cellular Reprogramming | 7 | 2024 | 203 | 1.710 |
Why?
|
| Fibroblasts | 10 | 2024 | 1654 | 1.630 |
Why?
|
| Myocardial Infarction | 7 | 2023 | 1181 | 1.420 |
Why?
|
| GATA4 Transcription Factor | 5 | 2024 | 45 | 1.410 |
Why?
|
| Cell Transdifferentiation | 5 | 2021 | 114 | 1.200 |
Why?
|
| Cellular Reprogramming Techniques | 4 | 2020 | 28 | 0.990 |
Why?
|
| T-Box Domain Proteins | 5 | 2022 | 154 | 0.870 |
Why?
|
| Endothelium | 1 | 2021 | 156 | 0.750 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2016 | 1580 | 0.650 |
Why?
|
| Myogenic Regulatory Factors | 2 | 2014 | 32 | 0.570 |
Why?
|
| Heart Diseases | 2 | 2023 | 724 | 0.570 |
Why?
|
| Regeneration | 2 | 2017 | 284 | 0.570 |
Why?
|
| Gene Transfer Techniques | 3 | 2016 | 804 | 0.550 |
Why?
|
| Lentivirus | 1 | 2017 | 164 | 0.550 |
Why?
|
| Fibrosis | 2 | 2017 | 733 | 0.540 |
Why?
|
| Rats | 11 | 2024 | 6441 | 0.520 |
Why?
|
| MEF2 Transcription Factors | 4 | 2017 | 43 | 0.400 |
Why?
|
| Ventricular Function | 1 | 2012 | 100 | 0.400 |
Why?
|
| Heart | 1 | 2017 | 1195 | 0.380 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 346 | 0.360 |
Why?
|
| Transcription Factors | 5 | 2024 | 5438 | 0.330 |
Why?
|
| Cell Differentiation | 2 | 2024 | 4116 | 0.330 |
Why?
|
| Coronary Artery Bypass | 3 | 2001 | 530 | 0.310 |
Why?
|
| Genetic Vectors | 4 | 2017 | 1857 | 0.290 |
Why?
|
| Myocardium | 5 | 2024 | 1232 | 0.230 |
Why?
|
| Endothelial Cells | 2 | 2021 | 1038 | 0.220 |
Why?
|
| Rats, Inbred F344 | 2 | 2014 | 239 | 0.220 |
Why?
|
| Animals | 17 | 2024 | 61956 | 0.220 |
Why?
|
| Technology | 1 | 2023 | 100 | 0.200 |
Why?
|
| Cell Plasticity | 1 | 2021 | 67 | 0.190 |
Why?
|
| Butyric Acid | 1 | 2020 | 15 | 0.180 |
Why?
|
| Heart Arrest, Induced | 1 | 2000 | 85 | 0.180 |
Why?
|
| Coculture Techniques | 1 | 2021 | 628 | 0.170 |
Why?
|
| Adenoviridae | 2 | 2016 | 1497 | 0.170 |
Why?
|
| Cell Separation | 1 | 2021 | 609 | 0.170 |
Why?
|
| Hemodynamics | 2 | 2000 | 949 | 0.170 |
Why?
|
| Myocardial Contraction | 1 | 2000 | 301 | 0.160 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 205 | 0.160 |
Why?
|
| Flow Cytometry | 3 | 2021 | 3045 | 0.160 |
Why?
|
| Intraoperative Complications | 1 | 2000 | 288 | 0.150 |
Why?
|
| Pyrimidinones | 1 | 2020 | 318 | 0.150 |
Why?
|
| Tretinoin | 1 | 2020 | 617 | 0.150 |
Why?
|
| Animals, Newborn | 1 | 2021 | 1368 | 0.140 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 43 | 0.140 |
Why?
|
| Snail Family Transcription Factors | 1 | 2017 | 120 | 0.140 |
Why?
|
| Fibronectins | 1 | 2017 | 205 | 0.140 |
Why?
|
| Collagen Type I | 1 | 2017 | 187 | 0.140 |
Why?
|
| Zinc Fingers | 1 | 2017 | 222 | 0.130 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 617 | 0.130 |
Why?
|
| Sp1 Transcription Factor | 1 | 2016 | 193 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2020 | 2156 | 0.130 |
Why?
|
| Gene Silencing | 1 | 2018 | 827 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2018 | 1624 | 0.120 |
Why?
|
| Prevalence | 1 | 2021 | 3404 | 0.110 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 1013 | 0.110 |
Why?
|
| Tissue Engineering | 2 | 2005 | 253 | 0.110 |
Why?
|
| Phosphoproteins | 1 | 2018 | 1138 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2017 | 2090 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2000 | 1042 | 0.100 |
Why?
|
| Models, Animal | 1 | 2014 | 657 | 0.090 |
Why?
|
| Heart Transplantation | 2 | 1996 | 897 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2017 | 1367 | 0.090 |
Why?
|
| Blood Flow Velocity | 2 | 1989 | 541 | 0.090 |
Why?
|
| Aortic Valve | 2 | 1992 | 445 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 1121 | 0.090 |
Why?
|
| Aorta | 2 | 1998 | 670 | 0.090 |
Why?
|
| Bioprosthesis | 2 | 1993 | 130 | 0.090 |
Why?
|
| Histones | 1 | 2017 | 1513 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 5002 | 0.080 |
Why?
|
| Rheology | 1 | 1988 | 47 | 0.080 |
Why?
|
| Arteriosclerosis | 1 | 1989 | 178 | 0.080 |
Why?
|
| Echocardiography | 2 | 2012 | 1228 | 0.080 |
Why?
|
| Heart Valve Prosthesis | 3 | 1993 | 306 | 0.080 |
Why?
|
| Leukemia | 1 | 2017 | 1719 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 7381 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2014 | 3584 | 0.080 |
Why?
|
| Transfection | 1 | 2012 | 3117 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 1989 | 196 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 2345 | 0.070 |
Why?
|
| Humans | 20 | 2024 | 270740 | 0.070 |
Why?
|
| Male | 16 | 2020 | 128315 | 0.070 |
Why?
|
| Extracellular Matrix | 2 | 2005 | 524 | 0.060 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2024 | 20 | 0.060 |
Why?
|
| Multipotent Stem Cells | 1 | 2024 | 53 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2024 | 12103 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2016 | 2887 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 294 | 0.050 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 1441 | 0.050 |
Why?
|
| Alginates | 1 | 2020 | 22 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2020 | 5694 | 0.050 |
Why?
|
| Diastole | 1 | 2000 | 187 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2000 | 116 | 0.040 |
Why?
|
| Mice | 4 | 2024 | 35600 | 0.040 |
Why?
|
| Aortic Valve Insufficiency | 2 | 1992 | 141 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2001 | 391 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2000 | 370 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2000 | 544 | 0.040 |
Why?
|
| Swine | 2 | 2016 | 1607 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2001 | 766 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2000 | 509 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 444 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2000 | 564 | 0.030 |
Why?
|
| Subclavian Vein | 1 | 1996 | 44 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 1158 | 0.030 |
Why?
|
| Troponin T | 1 | 2018 | 258 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2022 | 2196 | 0.030 |
Why?
|
| New Zealand | 1 | 1996 | 67 | 0.030 |
Why?
|
| Subclavian Artery | 1 | 1996 | 79 | 0.030 |
Why?
|
| Aneurysm | 1 | 1996 | 90 | 0.030 |
Why?
|
| Arteriovenous Fistula | 1 | 1996 | 101 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2017 | 586 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2000 | 1568 | 0.030 |
Why?
|
| Aged | 9 | 2001 | 73333 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 1697 | 0.030 |
Why?
|
| Waiting Lists | 1 | 1996 | 267 | 0.030 |
Why?
|
| Female | 13 | 2005 | 148940 | 0.030 |
Why?
|
| Tricuspid Valve | 1 | 1993 | 64 | 0.030 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 1993 | 66 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 628 | 0.030 |
Why?
|
| Cause of Death | 1 | 1996 | 789 | 0.030 |
Why?
|
| Heart Failure | 1 | 2005 | 2330 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 1998 | 587 | 0.020 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 1998 | 526 | 0.020 |
Why?
|
| Thrombosis | 1 | 1998 | 743 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2022 | 2928 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2012 | 33737 | 0.020 |
Why?
|
| Middle Aged | 7 | 2001 | 90352 | 0.020 |
Why?
|
| Myosins | 1 | 1990 | 97 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 4223 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 4130 | 0.020 |
Why?
|
| Mathematics | 1 | 1988 | 141 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 6509 | 0.020 |
Why?
|
| Leiomyosarcoma | 1 | 1990 | 253 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 1990 | 251 | 0.020 |
Why?
|
| Aortic Valve Stenosis | 1 | 1992 | 346 | 0.020 |
Why?
|
| Heart Block | 1 | 1987 | 45 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1987 | 115 | 0.020 |
Why?
|
| Mediastinal Neoplasms | 1 | 1990 | 427 | 0.020 |
Why?
|
| Graft Rejection | 1 | 1990 | 847 | 0.020 |
Why?
|
| Absorbable Implants | 1 | 2005 | 60 | 0.020 |
Why?
|
| Materials Testing | 1 | 2005 | 119 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 3438 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2005 | 60 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2005 | 165 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 2005 | 109 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2005 | 202 | 0.010 |
Why?
|
| Risk Factors | 2 | 2001 | 17888 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2005 | 593 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2005 | 533 | 0.010 |
Why?
|
| Survival Rate | 1 | 1996 | 12541 | 0.010 |
Why?
|
| Time Factors | 1 | 1996 | 13006 | 0.010 |
Why?
|
| Adult | 5 | 2001 | 82040 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2005 | 626 | 0.010 |
Why?
|
| Wound Healing | 1 | 2005 | 749 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2005 | 847 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1998 | 123 | 0.010 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1996 | 77 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 1990 | 3240 | 0.010 |
Why?
|
| Biomarkers | 1 | 2005 | 5051 | 0.010 |
Why?
|
| Endocarditis, Bacterial | 1 | 1992 | 152 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1992 | 183 | 0.010 |
Why?
|
| Macaca | 1 | 1990 | 88 | 0.010 |
Why?
|
| Abdominal Muscles | 1 | 1990 | 71 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2001 | 30998 | 0.010 |
Why?
|
| Calcinosis | 1 | 1992 | 426 | 0.000 |
Why?
|
| Random Allocation | 1 | 1990 | 741 | 0.000 |
Why?
|
| Necrosis | 1 | 1990 | 595 | 0.000 |
Why?
|
| Sick Sinus Syndrome | 1 | 1987 | 12 | 0.000 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1987 | 106 | 0.000 |
Why?
|
| Graft Survival | 1 | 1990 | 1083 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2001 | 5681 | 0.000 |
Why?
|
| Heart Arrest | 1 | 1990 | 382 | 0.000 |
Why?
|
| Adolescent | 2 | 1993 | 32767 | 0.000 |
Why?
|
| Child | 2 | 1993 | 30559 | 0.000 |
Why?
|
| Age Factors | 1 | 1987 | 5457 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1987 | 8699 | 0.000 |
Why?
|
| Infant | 1 | 1987 | 13999 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1987 | 17061 | 0.000 |
Why?
|